$149M On Recalled Test Kits

Federal agencies spent nearly $150 million on a Covid-19 test kit that didn’t work in clinical trials. Records show funding for Spartan Bioscience Inc. of Ottawa was approved only weeks before its test kits were recalled: “Results were not positive.”

This content is for Blacklock’s Reporter members only. Please login to view this content. (Register here.)

Back to Top